EGF and prostate carcinoma: Immunoblotting analyses of the F- and G-actin fractions showed that the relative expression level of F-actin/G-actin was significantly higher in EGF-stimulated 22Rv1, DU 145 and PC-3 prostate cancer cells compared to control cells (p<0.05; Figure 4C).